Soluble adhesion molecules and angiotensin-converting enzyme in dementia

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Adhesion receptors of the immune system

Springer, T. A. (1990) · Nature · doi:10.1038/346425a0 · Cited by 6,477 · see citing works

Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Leukocyte-endothelial adhesion molecules

Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.bloodjournal8472068 · Cited by 2,500 · see citing works

Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1).

Dustin, M. L., Rothlein, R., Bhan, A. K., Dinarello, C. A., & Springer, T. A. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.1.245 · Cited by 2,450 · see citing works

Leukocyte-endothelial adhesion molecules

Carlos, T., & Harlan, J. (1994) · Blood · doi:10.1182/blood.v84.7.2068.2068 · Cited by 1,957 · see citing works

Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy Lesions

Giasson, B. I., Duda, J. E., Murray, I. V. J., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q., & Lee, V. M. ‐. (2000) · Science · doi:10.1126/science.290.5493.985 · Cited by 1,551 · see citing works

Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases

Hwang, S., Ballantyne, C. M., Sharrett, A. R., Smith, L. C., DAVIS, C. E., Gotto, A. M., & Boerwinkle, E. (1997) · Circulation · doi:10.1161/01.cir.96.12.4219 · Cited by 1,340 · see citing works

Endothelial-Leukocyte Adhesion Molecules

Bevilacqua, M. P. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.004003 · Cited by 1,295 · see citing works

The prevalence of frontotemporal dementia

Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,151 · see citing works

Cerebral microvascular pathology in aging and Alzheimer's disease

Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102 · see citing works

Adhesion molecules and atherosclerosis

Blankenberg, S., Barbaux, S., & Tiret, L. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00097-2 · Cited by 1,075 · see citing works

IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1

Schleimer, R. P., Sterbinsky, S. A., Kaiser, J., Bickel, C., Klunk, D. A., Tomioka, K., Newman, W., Luscinskas, F. W., Gimbrone, M. A., & McIntyre, B. W. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1086 · Cited by 818 · see citing works

Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study

Ott, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792 · see citing works

Dementia with Lewy bodies.

McKeith, I. G. (2004) · Europe PMC (PubMed Central) · Cited by 756 · see citing works

APOLIPOPROTEIN E ALLELES AS RISK FACTORS IN ALZHEIMER'S DISEASE

Roses, M. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.387 · Cited by 707 · see citing works

β-Amyloid-mediated vasoactivity and vascular endothelial damage

Thomas, T., Thomas, G., McLendon, C., Sutton, T., & Mullan, M. (1996) · Nature · doi:10.1038/380168a0 · Cited by 703 · see citing works

A form of circulating ICAM-1 in human serum

Rothlein, R., Mainolfi, E. A., Czajkowski, M., et al. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3788 · Cited by 690 · see citing works

Untitled work

(2000) · PubMed · Cited by 683 · see citing works

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells

Pigott, R., Dillon, L. P., Hemingway, I., & Gearing, A. J. H. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91234-h · Cited by 650 · see citing works

Dementia with Lewy bodies

McKeith, I. G., Mintzer, J. E., Aarsland, D., Burn, D. J., Chiu, H. F. K., Cohen‐Mansfield, J., Dickson, D. W., Dubois, B., Duda, J. E., Feldman, H., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00619-7 · Cited by 618 · see citing works

Circulating Cell Adhesion Molecules and Death in Patients With Coronary Artery Disease

Blankenberg, S., Rupprecht, H. J., Bickel, C., Peetz, D., Hafner, G., Tiret, L., Meyer, J., & for the AtheroGene Investigators (2001) · Circulation · doi:10.1161/hc3701.095949 · Cited by 593 · see citing works

Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells.

Nagel, T., Resnick, N., Atkinson, W. J., Dewey, C. F., & Gimbrone, M. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117410 · Cited by 581 · see citing works

Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins

Casserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560 · see citing works

Regulation of intercellular adhesion molecule-1 (CD54) gene expression

Roebuck, K. A., & Finnegan, A. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.66.6.876 · Cited by 558 · see citing works

Vascular cell adhesion molecule-1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic progenitor cell mobilization by granulocyte colony-stimulating factor

Lévesque, J.-P., Takamatsu, Y., Nilsson, S. K., Haylock, D. N., & Simmons, P. J. (2001) · Blood · doi:10.1182/blood.v98.5.1289 · Cited by 486 · see citing works

Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.

Strittmatter, W. J., Saunders, A. M., Goedert, M., Weisgraber, K. H., Dong, L. M., Jakes, R., Huang, D. Y., Pericak-Vance, M., Schmechel, D., & Roses, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11183 · Cited by 474 · see citing works

Regulation of Phospholipase D2: Selective Inhibition of Mammalian Phospholipase D Isoenzymes by α- and β-Synucleins

Jenco, J. M., Rawlingson, A., Daniels, B., & Morris, A. J. (1998) · Biochemistry · doi:10.1021/bi972776r · Cited by 431 · see citing works

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy.

Mohs, R. C., Rosen, W. G., & Davis, K. L. (1983) · PubMed · Cited by 420 · see citing works

Angiotensin-converting enzyme: new concepts concerning its biological role.

Ehlers, M., & Riordan, J. (1989) · Biochemistry · doi:10.1021/bi00439a001 · Cited by 395 · see citing works

Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system.

Sobel, R. A., Mitchell, M. E., & Fondren, G. (1990) · PubMed · Cited by 390 · see citing works

Clearing amyloid through the blood-brain barrier

Zlokovic, B. V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02385.x · Cited by 336 · see citing works

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor ? and interleukin-1 in rheumatoid arthritis

Paleolog, E. M., Young, S., Stark, A. C., McCloskey, R. V., Feldmann, M., & Maini, R. N. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7 · Cited by 318 · see citing works

Amyloid Angiopathy–Related Vascular Cognitive Impairment

Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298 · see citing works

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease

Kehoe, P. G., Russ, C., McIlroy, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., et al. (1999) · Nature Genetics · doi:10.1038/5009 · Cited by 260 · see citing works

Cytokines in Neuroinflammation and Alzheimers Disease

Cacquevel, M., Lebeurrier, N., Chéenne, S., & Vivien, D. (2004) · Current Drug Targets · doi:10.2174/1389450043345308 · Cited by 245 · see citing works

Angiotensin II and vascular inflammation.

Cheng, Z. J., Vapaatalo, H., & Mervaala, E. M. A. (2005) · PubMed · Cited by 237 · see citing works

Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia

Zuliani, G., Ranzini, M., Guerra, G., Rossi, L., Munari, M. R., Zurlo, A., Volpato, S., Atti, A. R., Blè, A., & Fellin, R. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.008 · Cited by 234 · see citing works

Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan Study

Breteler, M. M. B. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06399.x · Cited by 234 · see citing works

β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1

Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K.-S., Zlokovic, B., & Kalra, V. K. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.6.c1772 · Cited by 218 · see citing works

Aβ deposition is associated with enhanced cortical α-synuclein lesions in Lewy body diseases

Pletniková, O., West, N. C., Lee, M. K., Rudow, G. L., Skolasky, R. L., Dawson, T. M., Marsh, L., & Troncoso, J. C. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.006 · Cited by 209 · see citing works

NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation.

Yoshimoto, M., Iwai, A., Kang, D. E., Otero, D. A., Xia, Y., & Saitoh, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9141 · Cited by 202 · see citing works

Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1

Buckley, C. D., Doyonnas, R., Newton, J. P., Blystone, S. D., Brown, E. J., Watt, S. M., & Simmons, D. L. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.2.437 · Cited by 197 · see citing works

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-α and blood-brain barrier damage

Sharief, M. K., Noori, M. A., Ciardi, M. R., Cirelli, A., & Thompson, E. J. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90070-f · Cited by 179 · see citing works

Measurement of Thirteen Biological Markers in CSF of Patients with Alzheimer’s Disease and Other Dementias

Blasko, I., Lederer, W., OBERBAUER, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170 · see citing works

Protein Analysis in Cerebrospinal Fluid

Blennow, K., Fredman, P., Wallin, A., Gottfries, C., Karlsson, I., Långstrom, G., Skoog, I. G., Svennerholm, L. T., & Wikkelsø, C. (2008) · European Neurology · doi:10.1159/000116919 · Cited by 169 · see citing works

Apolipoprotein E4 enhances brain inflammation by modulation of the NF-κB signaling cascade

Ophir, G., Amariglio, N., Jacob‐Hirsch, J., Elkon, R., Rechavi, G., & Michaelson, D. M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.002 · Cited by 166 · see citing works

Adhesion molecules on murine brain microvascular endothelial cells: expression and regulation of ICAM-1 and Lgp 55

Fábry, Z., Waldschmidt, M. M., Hendrickson, D., Keiner, J., Love-Homan, L., Takei, F., & HART, M. N. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90026-h · Cited by 155 · see citing works

Atherosclerosis of Cerebral Arteries in Alzheimer Disease

Roher, A. E., Esh, C. L., Rahman, A., Kokjohn, T. A., & Beach, T. G. (2004) · Stroke · doi:10.1161/01.str.0000143317.70478.b3 · Cited by 146 · see citing works

Alpha‐synuclein and its disease‐causing mutants induce ICAM‐1 and IL‐6 in human astrocytes and astrocytoma cells

Klegeris, A., Giasson, B. I., Zhang, H., Maguire, J. A., Pelech, S., & McGeer, P. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-6183com · Cited by 143 · see citing works

Expression of intercellular adhesion molecule (ICAM)-1 by a subset of astrocytes in Alzheimer disease and some other degenerative neurological disorders

Akiyama, H., Kawamata, T., Yamada, T., Tooyama, I., Ishii, T., & McGeer, P. L. (1993) · Acta Neuropathologica · doi:10.1007/bf00334673 · Cited by 137 · see citing works

ICAM-1-Induced Expression of Proinflammatory Cytokines in Astrocytes: Involvement of Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Pathways

Lee, S. J., Drabik, K., Van Wagoner, N. J., Lee, S., Choi, C., Dong, Y., & Benveniste, E. N. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4658 · Cited by 137 · see citing works

New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease

Morisaki, N. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)06083-8 · Cited by 133 · see citing works

Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients

Rota, E., Bellone, G., Rocca, P., Bergamasco, B., Emanuelli, G., & Ferrero, P. (2006) · Neurological Sciences · doi:10.1007/s10072-006-0562-6 · Cited by 125 · see citing works

Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease

Frohman, E. M., Frohman, T. C., Gupta, S., de Fougerolles, A., & van den Noort, S. (1991) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(91)90202-i · Cited by 120 · see citing works

Haplotypes extending across ACE are associated with Alzheimer's disease

Kehoe, P. G. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg094 · Cited by 119 · see citing works

Adhesion Molecules in Cerebrovascular Diseases

Fassbender, K. C., Bertsch, T., Mielke, O., Muehlhauser, F., & Hennerici, M. G. (1999) · Stroke · doi:10.1161/01.str.30.8.1647 · Cited by 118 · see citing works

Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: the roles of cytokines and CD40

Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., & Mullan, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00780-x · Cited by 116 · see citing works

Is angiotensin-II an endogenous pro-inflammatory molecule?

Das, U. N. (2005) · PubMed · Cited by 113 · see citing works

Endothelial adhesion molecules in health and disease.

Cotran, R. S., & Mayadas‐Norton, T. (1998) · PubMed · Cited by 108 · see citing works

Dementia in developing countries. A consensus statement from the 10/66 Dementia Research Group.

Prince, M. J. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(200001)15:1 · Cited by 108 · see citing works

Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts.

Fawcett, J., Buckley, C., Holness, C. L. L., Bird, I. N., Spragg, J. H., Saunders, J., Harris, A. L., & Simmons, D. L. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1229 · Cited by 107 · see citing works

Increased cerebrospinal fluid levels of transforming growth factor-β1 in Alzheimer’s disease

Zetterberg, H., Andreasen, N., & Blennow, K. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.001 · Cited by 101 · see citing works

Plasma and cerebrospinal fluid α1‐antichymotrypsin levels in Alzheimer's disease: Correlation with cognitive impairment

DeKosky, S. T., Ikonomović, M. D., Wang, X., Farlow, M. R., Wisniewski, S. R., López, O. L., Becker, J. T., Saxton, J. A., Klunk, W. E., Sweet, R. A., et al. (2002) · Annals of Neurology · doi:10.1002/ana.10414 · Cited by 97 · see citing works

Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: An indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier

Rieckmann, P., Nünke, K., Burchhardt, M., et al. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90023-r · Cited by 94 · see citing works

Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy

Zubenko, G. S., Volicer, L., Direnfeld, L. K., et al. (1985) · Brain Research · doi:10.1016/0006-8993(85)91032-7 · Cited by 86 · see citing works

Intrathecal chemokine levels in Alzheimer disease and frontotemporal lobar degeneration

Galimberti, D., Schoonenboom, N. S. M., Scheltens, P., Fenoglio, C., Venturelli, E., Pijnenburg, Y. A. L., Bresolin, N., & Scarpini, E. A. (2006) · Neurology · doi:10.1212/01.wnl.0000191324.08289.9d · Cited by 82 · see citing works

Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease

Xu, P., Li, Y., Qin, X., Scherzer, C. R., Xu, H., Schmechel, D. E., Hulette, C. M., Ervin, J. F., Gullans, S. R., Haines, J. L., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.07.004 · Cited by 76 · see citing works

Angiotensin-converting enzyme genotype is associated with Alzheimer disease in the Japanese population

Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Urakami, K., & Shoji, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00827-7 · Cited by 74 · see citing works

Association of Polymorphisms in the Angiotensin-Converting Enzyme Gene with Alzheimer Disease in an Israeli Arab Community

Meng, Y., Baldwin, C. T., Bowirrat, A., Waraska, K., Inzelberg, R., Friedland, R. P., & Farrer, L. A. (2006) · The American Journal of Human Genetics · doi:10.1086/503687 · Cited by 72 · see citing works

Expression of α-synuclein, the precursor of non-amyloid β component of Alzheimer's disease amyloid, in human cerebral blood vessels

Tamo, W., Imaizumi, T., Tanji, K., Yoshida, H., Mori, F., Yoshimoto, M., Takahashi, H., Fukuda, I., Wakabayashi, K., & Satoh, K. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00297-5 · Cited by 72 · see citing works

Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies

Singleton, A., Wharton, A., O’Brien, K. K., Walker, M. P., McKeith, I. G., Ballard, C. G., O'Brien, J. T., Perry, R. H., Ince, P. G., Edwardson, J. A., et al. (2002) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000066022 · Cited by 69 · see citing works

Intravascular infusions of soluble β-amyloid compromise the blood–brain barrier, activate CNS glial cells and induce peripheral hemorrhage

Su, G. C., Arendash, G. W., Kalaria, R. N., Bjugstad, K. B., & MULLAN, M. J. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01143-3 · Cited by 69 · see citing works

Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions

Losy, J., Niezgoda, A., & Wender, M. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00092-2 · Cited by 68 · see citing works

TGF‐β1 down‐regulates inflammatory cytokine‐induced VCAM‐1 expression in cultured human glomerular endothelial cells

Park, S.-K., Yang, W. S., Lee, S. K., Ahn, H., Park, J. S., Hwang, O., & Lee, J. D. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.5.596 · Cited by 67 · see citing works

ACE gene is associated with Alzheimer's disease and atrophy of hippocampus and amygdala

Sleegers, K., den Heijer, T., van Dijk, E. J., Albert Hofman, D., Bertoli‐Avella, A. M., Koudstaal, P. J., Breteler, M. M. B., & van Duijn, C. M. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.011 · Cited by 60 · see citing works

Characterization of α1-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma

Maes, O. C., Kravitz, S., Mawal, Y. R., Su, H., Liberman, A., Mehindate, K., Berlin, D., Sahlas, D. J., Chertkow, H. M., & Bergman, H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.009 · Cited by 54 · see citing works

Alzheimer's disease. A radical vascular connection.

Stamler, J. S. (1996) · PubMed · Cited by 53 · see citing works

A Vascular Connection to Alzheimer's Disease

Rhodin, J. A. G., & Thomas, T. R. (2001) · Microcirculation · doi:10.1080/713774033 · Cited by 52 · see citing works

A vascular connection to Alzheimer's disease.

Rhodin, J. A. G., & Thomas, T. (2001) · PubMed · doi:10.1038/sj/mn/7800086 · Cited by 50 · see citing works

Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes

Winkler, M. K., & Benveniste, E. N. (1998) · Glia · doi:10.1002/(sici)1098-1136(199802)22:2 · Cited by 50 · see citing works

Genetic association between the APOE * 4 allele and Lewy bodies in Alzheimer disease

Tsuang, D. W., Wilson, R. K., López, O. L., Luedecking‐Zimmer, E., Leverenz, J. B., DeKosky, S. T., Kamboh, M. I., & Hamilton, R. L. (2005) · Neurology · doi:10.1212/01.wnl.0000150892.81839.d1 · Cited by 50 · see citing works

TGF-β and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells

Gamble, J. R., Bradley, S., Noack, L., et al. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.7.949 · Cited by 46 · see citing works

The role of soluble intercellular adhesion molecules in neurodegenerative disorders

Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., & Vassilopoulos, D. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.001 · Cited by 45 · see citing works

Prevalence of vascular lesions in Dementia with Lewy Bodies. A postmortem study

Jellinger, K. A. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0824-x · Cited by 41 · see citing works

Angiotensin converting enzyme: an in vivo and in vitro marker of endothelial injury.

Matucci‐Cerinic, M., Jaffa, A. A., & Kahaleh, B. (1992) · PubMed · Cited by 40 · see citing works

In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens

Rhodin, J. A. G., Thomas, T. N., Clark, L. C., Garces, A. H., & Bryant, M. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5403 · Cited by 39 · see citing works

Soluble intercellular adhesion molecule-1 in serum and cerebrospinal fluid of clinically active relapsing-remitting multiple sclerosis

Trojano, M., Avolio, C., Simone, I. L., Defazio, G., Manzari, C., Robertis̄, F. D., Calò, A., & Livrea, P. (1996) · Neurology · doi:10.1212/wnl.47.6.1535 · Cited by 36 · see citing works

Signal transduction of β2m-induced expression of VCAM-1 and COX-2 in synovial fibroblasts

Chen, N. X., O’Neill, K. D., Niwa, T., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00136.x · Cited by 25 · see citing works

Pathogenic Factors in Vascular Dementia and Alzheimer’s Disease

Engelberg, H. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080034 · Cited by 19 · see citing works

Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system

Trojano, M., Avolio, C., Ruggieri, M., et al. (1998) · Multiple Sclerosis Journal · doi:10.1177/135245859800400110 · Cited by 19 · see citing works

Vascular complications in dementia with Lewy bodies: A postmortem study

Isojima, D., Togo, T., Kosaka, K., Fujishiro, H., Akatsu, H., Katsuse, O., Iritani, S., Matsumoto, T., & Hirayasu, Y. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00699.x · Cited by 17 · see citing works

Transforming growth factor (TGF)‐β1 inversely related to vascular cell adhesion molecule‐1 in postmenopausal women with coronary artery disease. A possible mechanism for the putative cardioprotective role of TGF‐β1?

Os, I., Djurovic, S., Seljeflot, I., et al. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00950.x · Cited by 14 · see citing works

Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study

Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10 · see citing works

The blood-brain barrier in Alzheimer’s disease

Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · see citing works

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease

Janelidze, S., Mattsson, N., Stomrud, E., Lindberg, O., Palmqvist, S., Zetterberg, H., Blennow, K., & Hansson, O. (2018) · Neurology · doi:10.1212/wnl.0000000000006082 · Cited by 359 · see citing works

The Coming of Age of the Angiotensin Hypothesis in Alzheimer’s Disease: Progress Toward Disease Prevention and Treatment?

Kehoe, P. G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171119 · Cited by 133 · see citing works

Blood-brain barrier leakage in Alzheimer’s disease: From discovery to clinical relevance

Nehra, G., Bauer, B., & Hartz, A. M. S. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108119 · Cited by 127 · see citing works

Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122 · see citing works

A peripheral signature of Alzheimer’s disease featuring microbiota-gut-brain axis markers

Marizzoni, M., Mirabelli, P., Mombelli, E., Coppola, L., Festari, C., Lopizzo, N., Luongo, D., Mazzelli, M., Naviglio, D., Blouin, J.-L., et al. (2023) · Alzheimer's Research & Therapy · doi:10.1186/s13195-023-01218-5 · Cited by 121 · see citing works

Altered CSF Orexin and α-Synuclein Levels in Dementia Patients

Wennström, M., Londos, E., Minthon, L., & Nielsen, H. M. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111655 · Cited by 104 · see citing works

Clinical significance of circulating vascular cell adhesion molecule-1 to white matter disintegrity in Alzheimer’s dementia

Huang, C.-W., Tsai, M.-H., Chen, N.-C., Chen, W.-H., Lu, Y.-T., Lui, C.-C., Chang, Y.-T., Chang, W.-N., Chang, A. Y. W., & Chang, C.-C. (2015) · Thrombosis and Haemostasis · doi:10.1160/th14-11-0938 · Cited by 82 · see citing works

Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD

Yang, L. L., Stiernborg, M., Skott, E., Söderström, Å., Giacobini, M., & Lavebratt, C. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.10.005 · Cited by 29 · see citing works

ICAM-1 protects neurons against Amyloid-β and improves cognitive behaviors in 5xFAD mice by inhibiting NF-Κb

Guha, S., Paidi, R. K., Goswami, S., Saha, P., & Biswas, S. C. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.11.021 · Cited by 26 · see citing works

Decoding Blood-Brain Barrier Dysfunction in Alzheimer's Disease: Innovations and Challenges in Multimodal MRI and PET Imaging Biomarkers.

Yin, H., Lu, Z., Deng, Y., Tian, X., & Gong, Q. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102952 · Cited by 6 · see citing works

Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report).

Jindahra, P., VEJJAJIVA, A., Witoonpanich, R., Sirisriro, R., Sritara, C., & Pulkes, T. (2004) · PubMed · Cited by 8 · see citing works

Cell adhesion molecules in neoplastic disease

Johnson, J. P. (1992) · International Journal of Clinical & Laboratory Research · doi:10.1007/bf02591399 · Cited by 17 · see citing works

Vascular cell adhesion molecule - a new approach to detect endothelial cell activation in MS and encephalitis in vivo

Mößner, R., Fassbender, K. C., Kühnen, J., et al. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00185.x · Cited by 13 · see citing works

Blood serum levels of vascular cell adhesion molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and endothelial leucocyte adhesion molecule-1 (ELAM-1) in diabetic retinopathy

Nowak, M., Wielkoszyński, T., Marek, B., et al. (2008) · Clinical and Experimental Medicine · doi:10.1007/s10238-008-0173-z · Cited by 48 · see citing works

Dyslipidemia, Diabetes, and Cell Adhesion Molecules

Abe, Y., El-Masri, B., Kimball, K. T., Pownall, H. J., Osmundsen, K., Smith, C. W., & Ballantyne, C. M. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_22